168 related articles for article (PubMed ID: 1687219)
1. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.
Weg VB; Watson ML; Cordeiro RS; Williams TJ
Eur J Pharmacol; 1991 Nov; 204(2):157-63. PubMed ID: 1687219
[TBL] [Abstract][Full Text] [Related]
2. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats.
Taira M; Kohno SW; Yamamura H; Ohata K
Agents Actions; 1988 Jun; 24(1-2):189-95. PubMed ID: 3407549
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Pedersen KE; Rigby PJ; Goldie RG
Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig.
Weg VB; Watson ML; Faccioli LH; Williams TJ
Br J Pharmacol; 1994 Sep; 113(1):35-42. PubMed ID: 7812629
[TBL] [Abstract][Full Text] [Related]
5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
6. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis.
Woodward DF; Wasserman MA; Weichman BM
Eur J Pharmacol; 1983 Sep; 93(1-2):9-19. PubMed ID: 6313400
[TBL] [Abstract][Full Text] [Related]
7. Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig.
Handley DA; Farley C; Deacon RW; Saunders RN
Prostaglandins Leukot Med; 1986 Mar; 21(3):269-77. PubMed ID: 3010331
[TBL] [Abstract][Full Text] [Related]
8. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis.
Hutchcroft BJ; Moore EG; Orange RP
J Allergy Clin Immunol; 1979 Jun; 63(6):376-82. PubMed ID: 36420
[TBL] [Abstract][Full Text] [Related]
9. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.
Inagaki N; Miura T; Ohira K; Nagai H; Xu QA; Koda A
J Pharmacobiodyn; 1990 May; 13(5):272-7. PubMed ID: 2177106
[TBL] [Abstract][Full Text] [Related]
10. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Detsouli A; Lefort J; Vargaftig BB
Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
[TBL] [Abstract][Full Text] [Related]
11. The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit.
Lohman IC; Halonen M
Am Rev Respir Dis; 1993 May; 147(5):1223-8. PubMed ID: 8484635
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
13. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor.
Okamoto H; Iwahisa Y; Terasawa M
Agents Actions; 1992 Mar; 35(3-4):149-58. PubMed ID: 1388318
[TBL] [Abstract][Full Text] [Related]
15. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
17. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.
Inagaki N; Goto S; Yamasaki M; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1986; 80(3):285-90. PubMed ID: 3087885
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
19. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.
Hashimoto M; Shinozaki Y; Katori M
Br J Pharmacol; 1993 Mar; 108(3):604-12. PubMed ID: 7682130
[TBL] [Abstract][Full Text] [Related]
20. Leucotrienes, SRS-A and the vascular manifestations of PCA.
Morley J; Page C; Paul W
Agents Actions; 1981 Dec; 11(6-7):585-7. PubMed ID: 6122355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
